High Court Declines To Hear Teva Declaratory Judgment Case
This article was originally published in The Pink Sheet Daily
Executive Summary
The Supreme Court on Oct. 11 declined to hear Teva's appeal of a ruling on the standards for bringing a declaratory judgment action for patent noninfringement
You may also be interested in...
Supreme Court Denial Of Apotex Cert Against Pfizer Could Negatively Impact Generic Firms
Canadian company had sought judgment on validity of a Zoloft patent before launching a sertraline generic.
Supreme Court Denial Of Apotex Cert Against Pfizer Could Negatively Impact Generic Firms
Canadian company had sought judgment on validity of a Zoloft patent before launching a sertraline generic.
Limited ANDA Overlap With Ivax Creates Strong Position For Part D Benefit, Teva Says
There is "substantial non-overlap" between Teva's and Ivax' abbreviated new drug applications, Teva North America CEO George Barrett said